Parkinson's Disease Trial, By Invitation NCT07698236 Sponsor: Ruijin Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT07698236
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 40 and 80 years who have been diagnosed with Parkinson's disease or a related condition, based on recognised international diagnostic guidelines.
  • People who have been taking levodopa or similar Parkinson's medications at a stable, unchanged dose for at least 4 weeks before joining, and whose condition has shown a response to levodopa — the medication regimen must stay the same throughout the study.
  • People whose Parkinson's symptoms, when measured while on medication, are at a moderate level or below on a standard disease staging scale (Hoehn and Yahr stage 3 or lower).
  • People with normal cognitive (thinking and memory) function, as measured by a standard screening test with a score of 24 or higher out of 30.
  • People who are able to keep a daily symptom diary and take part in study activities as required.
  • People who have read, understood, and signed a consent form agreeing to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another neurological (brain or nerve) or psychiatric (mental health) condition that could interfere with the study or its results.
  • People who have previously had deep brain stimulation surgery or any other invasive brain stimulation procedure.
  • People who have a bone, joint, or other physical condition that could affect their ability to walk or balance.
  • People for whom an MRI scan would not be suitable — for example, due to claustrophobia or other factors (confirm with trial site).
  • People who have a history of taking antipsychotic medications, antidepressants, or other medications that may affect dopamine levels in the brain.
  • People for whom electrical stimulation would not be safe — for example, those with an implanted heart pacemaker or a history of epilepsy.
  • People who have previously received electroconvulsive therapy (ECT), a treatment that uses electrical currents applied to the head.
  • People with serious ongoing health conditions, including significant heart disease, breathing problems, or reduced liver or kidney function.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
3 July 2026
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Efficacy of temporal interference stimulation (TIS) on motor symptoms in patients with idiopathic Parkinson's disease and Parkinsonian syndromes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov